1,3,5-Triazines: A promising scaffold for anticancer drugs development

Area of Science:

• Medicinal Chemistry
• Organic Chemistry
• Pharmacology

Background:

• 1,3,5-triazine derivatives are a class of heterocyclic compounds with diverse biological activities.
• Research into their potential as anticancer agents has been ongoing.
• Hetero-fused derivatives represent an important structural modification.

Purpose of the Study:

• To review the synthetic pathways of 1,3,5-triazine derivatives and their hetero-fused analogs.
• To summarize the reported antitumor activities of these compounds.
• To discuss structure-activity relationships and mechanisms of action.

Main Methods:

• Comprehensive literature search of scientific reports from 2000 to 2016.
• Analysis of synthetic methodologies for 1,3,5-triazine derivatives.
• Evaluation of preclinical and clinical data on antitumor efficacy.

Main Results:

• Numerous 1,3,5-triazine derivatives, both uncondensed and hetero-fused, exhibit significant antitumor properties.
• Structure-activity relationship studies provide insights into key structural features for anticancer activity.
• Several compounds have progressed into clinical development stages.

Conclusions:

• 1,3,5-triazine derivatives are a promising scaffold for the development of novel anticancer drugs.
• Further research into their synthesis and mechanism of action can lead to improved therapeutic agents.
• The clinical progression of some derivatives validates their therapeutic potential.